Antitrust Cases | Claims Compensation Bureau

Payment Card Interchange Fees | Healthcare | Financial | Auto | Travel | Other

Payment Card Interchange Fees

Litigation	Discover Card Excessive Fees Litigation
Settlement Fund	$1.2 Billion
Class Period	Jan. 1, 2007 – Dec. 31, 2023
Description / Eligibility	Companies that accepted Discover at any point during the class period may be eligible in this class action that alleges Discover misclassified certain credit cards and, as a result, charged members inflated interchange fees.

Litigation	Payment Card Interchange Fees (Visa/Mastercard)
Settlement Fund	$5.54 Billion
Class Period	Jan. 1, 2004 - Jan. 25, 2019
Description / Eligibility	Entities may be an eligible class member if they accepted Visa and/or MasterCard-branded debit and/or credit card payments between January 1, 2004 and January 25, 2019. *The deadline to file claims has elapsed. No-cost assistance is available from the Class Administrator and Class Counsel regarding the settlement. Additional information is available at the Court-approved website, www.paymentcardsettlement.com.

Get More Information

Healthcare

Litigation	Blue Cross Blue Shield Antitrust Litigation MDL 2406
Settlement Fund	$2.8 Billion
Class Period	Feb. 7, 2008 - Oct. 4, 2024
Description / Eligibility	Companies that provided healthcare services, equipment, or supplies in the U.S. to any patient who was insured by a Blue-Branded Commercial Health Benefit Product at any time during the class period.

Litigation	Prescription Opiates
Settlement Fund	$378 Million
Class Period	Jan. 1, 1996 – Sept. 3, 2024
Description / Eligibility	Companies that purchased, paid for, and/or reimbursed some or all the cost of opioid prescription drugs, and/or paid or reimbursed for treatments related to misuse, addiction, and/or overdose of opioid drugs on behalf of your members, employees, insureds, participants, or beneficiaries during the class period.

Litigation	Generic Pharmaceuticals
Settlement Fund	$733.5 Million
Class Period	May 1, 2009 – Mar. 5, 2024
Description / Eligibility	Companies that purchased, paid for, and/or reimbursed for prescription drugs on behalf of members, employees, insureds, participants, or beneficiaries, and/or companies that dispense drugs (including clinics, hospitals, and independent pharmacies) in the United States may be eligible to recover from one or more of dozens of lawsuits involving the purchase or sale of pharmaceuticals.

Get More Information

Financial

Litigation	Stock Loan Market
Settlement Fund	$580 Million
Class Period	Jan. 7, 2009 – Aug. 22, 2023
Description / Eligibility	Companies who, directly or through an agent, entered into Stock Loan Transactions with the Prime Broker Defendants, direct or indirect parents, subsidiaries, or divisions of the Prime Broker Defendants, or the Released Credit Suisse Parties.

Litigation	Libor-Based Financial Instruments
Settlement Fund	$196.4 Million
Class Period	Jan. 1, 2003 – Dec. 15, 2023
Description / Eligibility	Companies that transacted in financial instruments tied to the LIBOR-rate during the class period, you may be eligible for recoveries in the $196.4 Million remaining settlements.

Litigation	Interest Rate Swaps Antitrust Litigation
Settlement Fund	$71 Million
Class Period	Jan. 1, 2008 – TBD
Description / Eligibility	Companies who, directly or through an agent, entered into one or more U.S. Interest Rate Swap(s) (“IRS”) Transactions during the class period may be eligible.

Get More Information

Auto

Litigation	Automotive Parts (various) - Direct
Settlement Fund	$113.3 Million
Class Period	Jan. 1, 1995 – Sept. 18, 2021
Description / Eligibility	Companies that purchased certain automotive parts directly from manufacturers during the class period, may be eligible for recoveries from various pending settlements totaling $113.3 million.

Get More Information

Travel

Litigation	Transpacific Airline Travel
Settlement Fund	$90,150,000
Class Period	Jan 1, 2000 - Jun 15, 2015
Description / Eligibility	Settlement Class All persons and entities that purchased passenger air transportation originating in the United States that included at least one flight segment to Asia or Oceania, from Defendants or their co-conspirators, or any predecessor subsidiary, or affiliate thereof. If your company bought a ticket for air travel between January 1, 2000 and June 15, 2015 that included at least one flight segment between the U.S. and Asia or Oceania, it may be eligible for a recovery in the $90 million settlement so far.

Litigation	Domestic Airline Travel
Settlement Fund	"$60,000,000* *Partial Settlement"
Class Period	July 2011 - Jun 14, 2014
Description / Eligibility	If your company purchased air passenger transportation service for flights within the United States and its territories beginning July 1, 2011, it may be eligible for recovery.

Get More Information

Other

Litigation	Prescription Drug Settlements
Settlement Fund	Various
Class Period	Various
Description / Eligibility	Companies that directly or indirectly purchased, paid and/or reimbursed prescription drugs on or after January 1, 1999 may be eligible for recoveries in these settlements.

Get More Information